Conclusion: The use of GLP1-RAs demonstrates efficacy in reducing BMI, triglycerides, waist circumference and total testosterone. There was no significant difference in total cholesterol and HOMA-IR levels. These results signify its viability as a favourable treatment option for managing PCOS symptoms in women living with obesity.
PubMed 39178623 ↗GLP-1 Agonists
The short answer. There isn't much data on GLP-1 Agonists yet — 11 mentions, 8 with a clear outcome — so treat these numbers as anecdotal. It is most often used for weight loss: 100% of 6 reports say that improved. It is well studied — 102 meta-analyses on PubMed.
From 11 mentions in total — the rest didn't say how it went and aren't counted.
What GLP-1 Agonists does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 102 meta-analyses on PubMed ↗ · 20 randomized trials ↗
Conclusion: Thirty-eight studies were included in this systematic review. GLP-1 analogues have demonstrated a notable impact on the composition, richness, and diversity of gut microbiota. We can conclude, following the obtained research results of our study, that liraglutide promotes the growth of beneficial genera relevant for beneficial metabolic functions. Exenatide and exendin-4 administration showed various effects on the microbiome composition in animal and human studies. In animal models, it increased genera associated with improved metabolism; however, in human models, genera linked to better meta
PubMed 40284168 ↗Conclusion: GLP-1 agonists are efficacious in treating children with obesity and/or T2DM. Effect sizes are comparable with those reported in adults.
PubMed 33354917 ↗Conclusion: This review underscores the potential role of GLP-1 agonists in BED management. However, given the limited data, especially concerning EDs other than BED and the long-term effects of these medications, further comprehensive clinical trials are recommended to evaluate the impact of various GLP-1 agonists on different EDs across diverse demographic groups.
PubMed 39891848 ↗241 human trials on ClinicalTrials.gov test GLP-1 Agonists — 81 completed, 67 recruiting now. See all on ClinicalTrials.gov ↗
- Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota · GLP-1, Weight Loss Trajectory · 2025
- Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists · glp1 Agonist, Gene Expression · 2026
- Probiotics in Obese Patients Treated With GLP-1 Receptor Agonists · Obesity (Disorder), GLP-1 Receptor Agonist Treatment · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 2 research projects with GLP-1 Agonists in the title, $2,702,157 in total (2021–2026). NIH RePORTER ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“my 70-something dad’s GLP-1... has been a complete game changer. Not only has he lost a ton of weight”
Top discussions (5)
- No free lunch: Ozempic type Weight-loss drugs draw thousands of lawsuits alleging serious harm. 75% of the lawsuits have to do with stomach paralysis ↗
- Ozempic will disrupt big tobacco, candy companies, and alcohol brands, according to Morgan Stanley ↗
- My top 10 takeaways from Rhonda Patrick's new episode with Dr. Ben Bikman about insulin resistance ↗
- Question for the peptide people ↗
- Nootropics that helped you with quitting your addiction? ↗
Other options for weight loss
Sources
- User reports: 11 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate